| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 67 |
| 1 | METHOTREXATE SODIUM | 67 |
| 2 | ADALIMUMAB | 64 |
| 3 | METHOTREXATE | 61 |
| 4 | ETANERCEPT | 56 |
| 5 | ABATACEPT | 54 |
| 6 | LEFLUNOMIDE | 54 |
| 7 | RITUXIMAB | 52 |
| 8 | TOFACITINIB | 50 |
| 9 | PREDNISONE | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SILTUXIMAB | 9 | 0.0139 |
| 1 | ELOSULFASE ALFA | 8 | 0.0015 |
| 2 | GALSULFASE | 5 | 0.0013 |
| 3 | CANAKINUMAB | 9 | 0.0008 |
| 4 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 5 | TOFACITINIB CITRATE | 9 | 0.0007 |
| 6 | FLURBIPROFEN | 1 | 0.0007 |
| 7 | VECURONIUM BROMIDE | 1 | 0.0007 |
| 8 | LEFLUNOMIDE | 54 | 0.0005 |
| 9 | ABATACEPT | 54 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 9 | 0.0139 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 13 | 0.0010 |
| 2 | Antirheumatic Agent [EPC] | 54 | 0.0005 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 54 | 0.0004 |
| 4 | Calcitonin [EPC] | 1 | 0.0003 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 52 | 0.0002 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 61 | 0.0001 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 11 | 0.0001 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 70 | 0.0001 |
| 9 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |